(ü 257) |
|
|
|
|
[] WFH, 2022 ۷ι ǥ
WFH Ȩ 2022 ۷ι (Annual Global Survey, AGS) Ͽٰ . ۷ι WFH 'θ ġ' ǥ ϴ
Ȳ
2023-11-16
|
|
|
|
|
[] Ʈ 뺸ũ, 캴A ġḦ
Ʈ ̾(Genevant Sciences) 뺸ũ(Novo Nordisk) Ͽ Ʈ (lipid nanoparticle, LNP) ÷ ÷ mRNA megaTAL 캴A
Ȳ
2023-11-16
|
|
|
|
|
[] SerpinPC, 캴B üȯڿ ù ӻ
(Centessa Pharmaceuticals) ȸ ǥڷḦ SerpinPC ȿ ϴ 2b ӻ迡 ü ִ ù° ڰ Ҵٰ ߴ. ߺι ְ ̹(Ant
Ȳ
2023-11-15
|
|
|
|
|
[] ij, 캴B ġ 'н'
ij Ǻδ ϰų ̱ ϻ ϴ 캴B ȯڸ ġϱ ġ ɼ ġ н(Hemgenix, etranacogene dezaparvovec) ߴٰ ǥߴ.
Ȳ
2023-11-09
|
|
|
|
|
[] ̱ 캴
캴 ȯ ̱ ο ̿ 캴 ɼ . ƲŸ ڵ ǥ ʹ ̱ 캴 ̡
Ȳ
2023-11-09
|
|
|
|
|
[] 캴 ȯ, Ѿ
2,700 ̻ 캴 ȯ, ǷἭ ڸ ȯ Ȱ Ȱϰų 캴 ȯڸ ϻ 硱 ȯڰ ڽ Ǿ.
Ȳ
2023-10-26
|
|
|
|
|
[] ȭ ٷ° ɷ¿ ū
캴 ȯڿԼ ǰ ִ Ư ִٴ Ǿ. ȭ, ջ ٷ Ʈ ȯ ɷ¿ ߿ , ȭε κ ° Ʈ ȭ
Ȳ
2023-10-22
|
|
|
|
|
[] Ʈ, ӻ Ϳ ҽŰ Ÿ
2 3 ӻ Ϳ Ʈ(Eloctate, efmoroctocog alfa) ִ 5 ġ , 캴A ִ Ҿ, ûҳ ϴ Ÿ
Ȳ
2023-10-20
|
|
|
|
|
[] 캴A '' Ϻ 븸
(Sanofi) (Altuviiio, efanesoctocog alfa) Ϻ 븸 캴A ȯ ϰ ϴµ ִ ġμ εǾ. ̱ ƽþ κ Ǹϰ ִ
Ȳ
2023-10-18
|
|
|
|
|
[] FDA, 캴A ü ġ TI-168 Ǿǰ
캴 ġ 忡 ݰ Ͽ ֻ پ ǰ ġ ɼǵ ϰ ִ ̱ ǰǾ౹(FDA) ü ִ 캴A ȯڸ ġϱ ڽ ̿(Baudax Bio) T(Treg)
Ȳ
2023-10-18
|
|
|
|
|
[] ȯ ִ 5
ϻӿ 츮 ϰ մϴ. (Jared) 캴 ΰ ִµ, ָ Ȱ ư 츮Դ 鿡Դ ſ Ư Ȳ 츮 ڸ
Ȳ
2023-10-04
|
|
|
|
|
[] , 캴B '̵' ǥ
ο '̵'(Idelvion, albutrepenonacog alfa) ġ 캴B ȯڵ ȿ ϰ ִ Ÿ. 캴B ȯ rIX-FP :
Ȳ
2023-10-02
|
|
|
|
|
[] 캴A ü
8 (FVIII) Ҹ ܹ ̵ 캴A ȯڿԼ FVIII ü 鿪 ڱ ִٴ . FVIII ̷ 鿪 Ϸ Ư 鿪 ϸ
Ȳ
2023-10-02
|
|
|
|
|
[] 캴 ݰ, ̴µ ȿ
ݰ ϴ 캴 ȯڰ ֹ ġ( ġ ) ġ ȯϸ پ ǰ 캴 ȯ ִٰ Ÿ. 100 ̻ 캴 ȯ
Ȳ
2023-09-27
|
|
|
|
|
[] FDA, 8 Ȱ ϴ ű þ
̱ ǰǾ౹(FDA) ÿ 8 (FVIII) ϴ ϳμ Ʈ þ ǰ 'CRYOcheck Factor VIII Deficient Plasma with VWF'
Ȳ
2023-09-25
|
|
|
|
|
[] 캴 ȯڿ Ҿ
ƢŰ ֱ м ҿ 캴 A B ΰ ִ 4 1(24.4%) ӻ ʰ 4 3(74.4%) Ҿ ٰ . з¿ Ҿ
Ȳ
2023-09-20
|
|
|
|
|
|
|
[] ̱, '̱ȯ'
ֱ ̱캴(NHF) ̱ȯ(National Blooding Disorders Foundation, NBDF) Ī 캴 ̿ ȯ 鿡 ڴٴ .
2023-08-29
|
|
|
|
|
[] "캴 ġῡ ġ "
캴 ȯ ǥ ü 쿬(World Federation of Hemophilia / WFH) 1117Ϻ Ʋ ij Ʈÿ 13ȸ ۷ι(Global Forum) ٰ ˷ȴ.WFH
2023-08-25
|
|
|
|
|
[] ν, 캴A ġ SPK-8011 3 ӻ
ν(Roche) 캴A ȯ ġḦ ġ SPK-8011 3 ӻ Ѵٰ ǥߴ. ν ̹ ǥ 2023 ݱ ǥ ̴. ̿ ÿ SPK-8016̶ ٸ 캴A
Ȳ
2023-08-06
|
|
|